Lidocaína B. Braun

Lidocaine, the active ingredient in Lidocaína B. Braun, is a local anesthetic presented as a sterile solution for epidural, infiltration and intradermal administration. It produces reversible nerve block by inhibiting sodium channels, providing temporary loss of pain and sensation during minor surgical, diagnostic or therapeutic procedures in adult patients.

GNH USA supplies Lidocaína B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance for the European market and other healthcare facilities seeking reliable anesthetic solutions.

Lidocaine is a local anesthetic used to achieve regional nerve blockade in various clinical settings.

- Epidural anesthesia: provides analgesia for labor, surgery, or postoperative pain control. - Local infiltration anesthesia: numbs tissue at the site of minor surgical or dental procedures. - Intradermal anesthesia: facilitates diagnostic skin testing or minor dermatologic interventions.

Lidocaine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Tingling or numbness at the injection site. - Mild dizziness or light‑headedness. - Transient visual disturbances. - Nausea or mild vomiting.

Serious or Rare Side Effects: - Cardiovascular collapse or severe hypotension. - Cardiac arrhythmias, including ventricular tachycardia. - Central nervous system seizures. - Allergic reactions such as rash, angioedema or anaphylaxis.

When using Lidocaína B. Braun, clinicians should observe several safety measures to minimize risk.

- Patient assessment: evaluate cardiac history and conduction abnormalities before administration. - Dose calculation: adjust dose for elderly or patients with hepatic impairment. - Monitoring: observe vital signs and ECG during epidural or high‑dose infiltration. - Drug interactions: avoid concurrent use with class I antiarrhythmics or other local anesthetics. - Allergy check: confirm no known hypersensitivity to amide‑type anesthetics. - Store at ambient temperature: keep below 25 °C, protect from light and moisture in original container.

Lidocaine can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Class I antiarrhythmic agents (e.g., quinidine, procainamide): may cause additive cardiotoxicity. - Other local anesthetics: increase risk of systemic toxicity. - CYP3A4 inhibitors (e.g., ketoconazole): raise plasma lidocaine levels.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may enhance bradycardia. - Calcium channel blockers: can potentiate hypotensive effects. - Diuretics (e.g., furosemide): may reduce plasma protein binding, increasing free lidocaine.